A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa

Clin Nucl Med. 2023 Jan 1;48(1):e26-e27. doi: 10.1097/RLU.0000000000004385. Epub 2022 Sep 6.

Abstract

A 41-year-old woman with invasive lobular carcinoma of the breast underwent sequential 68Ga-PSMA-11 PET/CT and 18F-fluciclovine PET/CT as part of an ongoing clinical trial (NCT04750473). 68Ga-PSMA PET/CT showed increased radiotracer uptake in the uterine endometrium and left adnexa. 18F-fluciclovine PET/CT showed increased radiotracer uptake in a leiomyomatous uterus. A clinical 18F-FDG PET/CT demonstrated radiotracer uptake in the endometrium and a circumferential area of uptake in the left adnexa, a pattern more similar to the 68Ga-PSMA uptake pattern. This case highlights the discordance in the uptake pattern of 2 radiotracers approved for prostate cancer imaging but increasingly used in non-prostate malignancies imaging.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Fluorodeoxyglucose F18*
  • Gallium Radioisotopes
  • Humans
  • Male
  • Positron Emission Tomography Computed Tomography / methods
  • Prostatic Neoplasms* / pathology
  • Uterus / pathology

Substances

  • gallium 68 PSMA-11
  • Fluorodeoxyglucose F18
  • Gallium Radioisotopes
  • fluciclovine F-18